Centrophenoxine, also known as Lucidril or meclofenoxateor, combines PCPA (paracholrphenoxyacetic) and DMAE (dimethylaminoethanol) (Antiaging-systems.com, 2014). Recognized as one of the original drugs combat aging, Centrophenoxine was found from early animal studies to reduce lipofuscin levels (South, 2014). Europeans use the drug to promote brain energy, or neuroenergizing, with glucose uptake (Eternity-medicine.com, 2014). It is cholinergic, promoting absorption of DMAE (Examine.com, 2014).
Applications
Centrophenoxine is an over-the-counter oral supplement recommended for prevention and treatment of senile dementia, notably Alzheimer’s disease; it can also be effective for correction of cognitive decline and loss of memory (Marcer and Hopkins, 1977). There are ...
